X

Trial Profile

Randomised trial to evaluate the clinical value of intensive glucose monitoring and regulation in Myocardial Infarction.

Status: Active, no longer recruiting

Phase of Trial: Phase IV

Latest Information Update: 14 Aug 2012

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Insulin aspart (Primary)
Indications Myocardial infarction
Focus Biomarker; Therapeutic Use
Acronyms BIOMArCS-2

Most Recent Events

04 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by Netherlands Trial Register.
31 Aug 2011 Planned end date (Feb 2012) added as reported by Netherlands Trial Register.
31 Aug 2011 Status changed from not stated to recruiting as reported by Netherlands Trial Register.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com